bcl-2 gene (Neuro-Genesis/MIT)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug Namebcl-2 gene (Neuro-Genesis/MIT)
Drug Alias Namenerve regeneration therapy (Neuro-Genesis/MIT)
ClassificationBiologics
Mechanisms of ActionApoptosis regulator Bcl-2 modulators
TargetsApoptosis regulator Bcl-2
Therapy Area/IndicationsWounds and Injuries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMassachusetts Institute Of Technology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNeuro-Genesis IncMassachusetts Institute Of Technology
Active IndicationsN/A
Inactive IndicationsWounds and Injuries

Other Information

ATC CodeN/A
Related LinksN/A